Replies to post #642851 on NorthWest Biotherapeutics Inc (NWBO)

[RobotDroid]

I have always believed this, but nwbo keeps dangling carrots that are not really there. Their path to approval has been poorly executed.

[HappyLibrarian]

I believe that should happen in the first half of next year, hopefully in the first quarter.

I know it sounds like a long time, but I believe that we'll have a lot of other positive news between now and then.

For patients it’s objectively a long time, too long in fact.

For investors it is different but at a certain point, which we’re well past, it’s a long wait, especially when taken in context.

The issue is not that waiting until 1H 2024 when we’ve been waiting 3 years data lock and we’ll over a year since Top-Line Data.

The issue is not that we shareholders are unwilling to say “Okay another 4 to 6 months but that’s it!”

We have been willing to say tgat.

The issue is that NWBO never takes the deal.

They just add a few months here and a few months there and soon we are talking years.

Even the two or three week process of releasing TLD turned into a year and a half.

If I had said it would take more than 3 years on October 5, 2020 for NWBO to even apply to the easiest, most friendly regulator I would have been attacked for that viciously.

This is not okay, and it’s not normal.

As for other positive news, there will be little of any impact on the SP, let alone ‘lots’ and Daly that is normal, at least around here.